1. Home
  2. CPAC vs AKBA Comparison

CPAC vs AKBA Comparison

Compare CPAC & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$10.53

Market Cap

905.9M

Sector

Industrials

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.67

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPAC
AKBA
Founded
1949
2007
Country
Peru
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
905.9M
729.1M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
CPAC
AKBA
Price
$10.53
$1.67
Analyst Decision
Sell
Strong Buy
Analyst Count
2
6
Target Price
$10.15
$6.25
AVG Volume (30 Days)
203.3K
3.1M
Earning Date
02-13-2026
11-10-2025
Dividend Yield
5.31%
N/A
EPS Growth
20.27
N/A
EPS
0.15
N/A
Revenue
$601,081,883.00
$225,071,000.00
Revenue This Year
$9.96
$52.38
Revenue Next Year
$1.70
$22.45
P/E Ratio
$13.74
N/A
Revenue Growth
6.18
32.49
52 Week Low
$5.10
$1.45
52 Week High
$11.30
$4.08

Technical Indicators

Market Signals
Indicator
CPAC
AKBA
Relative Strength Index (RSI) 72.30 45.76
Support Level $10.14 $1.61
Resistance Level $10.73 $1.71
Average True Range (ATR) 0.55 0.07
MACD 0.29 0.04
Stochastic Oscillator 78.13 67.50

Price Performance

Historical Comparison
CPAC
AKBA

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: